Search Results - "Pal, Sridhar E"

Multicenter trial of EC145 in advanced, folate-receptor positive adenocarcinoma of the lung by Edelman, Martin J, Harb, Wael A, Pal, Sridhar E, Boccia, Ralph V, Kraut, Michael J, Bonomi, Philip, Conley, Barbara A, Rogers, John S, Messmann, Richard A, Garon, Edward B

“…EC145 is a novel folate-receptor targeted agent consisting of a folate molecule linked to a vinca alkaloid. EC20 is a technetium-labeled folate that assesses…”
Get more information

Phase II prospective trial of primary lung tumor stereotactic body radiation therapy (SBRT) followed by concurrent mediastinal chemoradiation and adjuvant immunotherapy for locally-advanced non-small cell lung cancer (NSCLC): Planned toxicity analysis by Heinzerling, John H, Mileham, Kathryn Finch, Robinson, Myra M., Symanowski, James Thomas, Induru, Raghava Reddy, Prabhu, Roshan Sudhir, Gant, Dean A., Pal, Sridhar E., Haggstrom, Daniel Ernest, Kim, Edward S., Burri, Stuart, Simone, Charles B.

“…Abstract only e21047 Background: The care of pts with locally-advanced NSCLC has continued to evolve. Dose escalation with conventional radiation and…”
Get full text

Response to Tositumomab and Iodine 131I-Tositumomab (BEXXAR) Based on International Prognostic Index (IPI) Score by Pal, Sridhar E., Winer, Eric S., Chin, Kevin, Dungy, Alisa, Higgins, Beth, Foss, Francine

“…Purpose: The therapeutic efficacy of Bexaar (tositumomab and131I tositumomab) in the treatment of follicular lymphoma patients who have relapsed or had…”
Get full text